Coronary Artery Disease in Patients on Dialysis: Impact of Traditional Risk Factors

Dario Nakić1,2, Petra Grbić Pavlović1, Marina Vojković1

  • 1Department of Nephrology, General Hospital Zadar, Bože Peričića 5, 23000 Zadar, Croatia.

PubMed

Insights

End-stage kidney disease patients on dialysis face high cardiovascular risks. Hypertension, dyslipidemia, and age significantly predict coronary artery disease development in this population.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • End-stage kidney disease (ESKD) significantly increases cardiovascular morbidity and mortality.
  • Coronary artery disease (CAD) is a major concern for patients undergoing dialysis.
  • Identifying traditional risk factors for CAD in ESKD patients is crucial for risk stratification and management.

Purpose of the Study:

  • To evaluate the contribution of traditional risk factors to the development of coronary artery disease (CAD).
  • To assess the prevalence of CAD in patients with end-stage kidney disease (ESKD) on dialysis.

Main Methods:

  • Coronary angiography was performed on 54 dialysis patients with symptoms or positive stress tests.
  • Significant CAD was defined as >70% lumen diameter obstruction.
  • Traditional risk factors analyzed included hypertension, diabetes, smoking, dyslipidemia, age, gender, and dialysis duration.

Main Results:

  • CAD was present in 34 (62.96%) of the 54 patients.
  • Hypertension was highly prevalent (92.59% overall, 97.05% in CAD group).
  • Dyslipidemia (OR 3.698) and older age (OR 1.056) were significant predictors of CAD, alongside hypertension.

Conclusions:

  • Hypertension, dyslipidemia, and age are significant predictors of coronary artery disease in patients with end-stage kidney disease on dialysis.
  • These findings highlight the importance of managing traditional cardiovascular risk factors in this vulnerable population.
  • Further large-scale studies are warranted to confirm these associations and guide clinical practice.

Related Concept Videos

Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
277
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
404
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
352
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
62
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
69
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
511